Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Tvardi Therapeutics (TVRD) Operating Margin (2016 - 2025)

Tvardi Therapeutics' Operating Margin history spans 13 years, with the latest figure at 92.88% for Q1 2025.

  • On a quarterly basis, Operating Margin rose 129663.0% to 92.88% in Q1 2025 year-over-year; TTM through Mar 2025 was 344.01%, a 38518.0% increase, with the full-year FY2024 number at 393.82%, up 18561.0% from a year prior.
  • Operating Margin hit 92.88% in Q1 2025 for Tvardi Therapeutics, up from 742.41% in the prior quarter.
  • Over the last five years, Operating Margin for TVRD hit a ceiling of 5.54% in Q3 2021 and a floor of 4083.07% in Q4 2021.
  • Historically, Operating Margin has averaged 803.42% across 5 years, with a median of 588.28% in 2022.
  • Biggest five-year swings in Operating Margin: crashed -415325bps in 2021 and later skyrocketed 312303bps in 2022.
  • Tracing TVRD's Operating Margin over 5 years: stood at 4083.07% in 2021, then skyrocketed by 76bps to 960.04% in 2022, then dropped by -13bps to 1085.45% in 2023, then skyrocketed by 32bps to 742.41% in 2024, then soared by 87bps to 92.88% in 2025.
  • Business Quant data shows Operating Margin for TVRD at 92.88% in Q1 2025, 742.41% in Q4 2024, and 222.07% in Q3 2024.